Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 41680255 | 4168025 | 5 | F | 200307 | 20160831 | 20040714 | 20160831 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-12630455 | BRISTOL MYERS SQUIBB | 29.00 | YR | F | Y | 0.00000 | 20160831 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 41680255 | 4168025 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 50 MG, QD | 21436 | 50 | MG | QD | |||||||
| 41680255 | 4168025 | 2 | C | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | Unknown | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 41680255 | 4168025 | 1 | Schizoaffective disorder |
| 41680255 | 4168025 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 41680255 | 4168025 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 41680255 | 4168025 | Caesarean section | |
| 41680255 | 4168025 | Live birth | |
| 41680255 | 4168025 | Maternal exposure during pregnancy | |
| 41680255 | 4168025 | Prescribed overdose | |
| 41680255 | 4168025 | Pruritus | |
| 41680255 | 4168025 | Twin pregnancy | |
| 41680255 | 4168025 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |